Clinical Trials
| Name of Trial | Description |
| The Gilead – DIVERSITY Study | A study to evaluate the efficacy and safety of the orally administered drug Filgotinib for the treatment of active Crohn’s disease. |
| Creatine Supplementation Study | A study to evaluate dietary creatine supplementation for the reduction of mucosal inflammation through improved epithelial barrier function of active Ulcerative colitis. |
| ADMIRE-CD II | A study to evaluate the safety and efficacy of Cx601, adult allogenic expanded adipose-derived stem cells, for the treatment of complex perianal fistula(s) in patients with Crohn’s disease. |
| TAK-018-2001 | A study to evaluate the safety, tolerability and early proof of concept of TAK-018 for the prevention of postoperative Crohn’s disease recurrence. |
Please contact Lucy Smigiel for more information:
Email: Lucy.Smigiel@cuanschutz.edu
Phone: 303-724-9143